Juergen Wolf
University of Cologne · 237 works · 2,910 citations · h-index 26
Top works
- BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
- Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed- Sternberg cells of a Hodgkin's lymphoma patient
- Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells
- Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease
- The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272
- Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331☆
- 14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group
- Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
- Deutsche Hodgkin-Lymphom-Studiengruppe (DHSG): 20 Jahre Diagnostik, Therapie und Nachsorge von Patienten mit Morbus Hodgkin
- Epidemiology and etiology of Hodgkin's lymphoma
- ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
- Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
- Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins.
- BEACOPP: A new regimen for advanced Hodgkin’s disease
- OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
- Prognostic factors in Hodgkin's lymphoma
- Prädiktive PD-L1-Immunhistochemie beim nichtkleinzelligen Bronchialkarzinom
- Das nationale Netzwerk Genomische Medizin (nNGM)
- Hodgkin's lymphoma-derived tissue serially transplanted into severe combined immunodeficient mice
- An open-label study of vandetanib with pemetrexed in patients with previously treated non-small-cell lung cancer